People carry the TRIM63 gene to help heart and skeletal muscle cells clear and replace worn out proteins. This gene plays an important role in keeping muscle tissue balanced as it adapts to exercise, illness, and daily wear. If it does not work properly, protein handling can go off track, which may lead to thickening of the heart muscle and, in some people, muscle weakness.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the instructions for making proteins, the parts of cells that do the work. Others mainly help determine when certain processes happen, where they happen, and how strongly they are carried out. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. For a closer look at this topic, you can find more in the LearnHub.
Overview
TRIM63Gene function
What if the gene works
The TRIM63 gene helps heart and skeletal muscle cells recycle worn out proteins. This supports normal muscle upkeep and adaptation during exercise, illness, and other physical stress.
Risk
What if the gene does not work
Variants in the TRIM63 gene are linked to hypertrophic cardiomyopathy, where the heart muscle becomes abnormally thick. Effects can be mild or severe and may appear later or earlier, depending on the variant and whether both gene copies are affected.
Treatment
What does that mean for your treatment
No treatment or drug choice specific to a pathogenic variant in the TRIM63 gene is currently established in clinical guidelines; care follows standard management for the related heart or muscle condition. The TRIM63 gene is being studied as a biomarker and possible drug target in muscle wasting and heart disease, but this has not changed routine treatment.
Gene function
What if the gene works
The TRIM63 gene is most active in skeletal and heart muscle, where cells constantly maintain large, hard working protein structures. It helps muscle fibers renew older parts and keep their internal machinery in order. These everyday jobs are the core of normal TRIM63 gene function in muscle.
In muscle cells, the TRIM63 gene helps tag older or worn proteins for breakdown and reuse. This cleanup process supports normal protein turnover and helps keep muscle cells balanced.
Its protein works on parts of the sarcomere (the tiny unit that lets muscle fibers shorten and relax). This helps keep the contractile machinery organized as muscles move, lift, and pump blood.
The TRIM63 gene helps muscles adjust protein turnover when workload or energy supply changes. This supports day to day balance in skeletal muscle and heart muscle.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help create normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
How the TRIM63 gene’s variants affect protein function depends on the change itself. Some variants slightly alter the protein’s shape or stability, while more disruptive variants can sharply reduce or stop its enzyme tag-adding activity (a cell process that marks proteins for breakdown) or weaken its binding to partner proteins. In TRIM63-related cardiomyopathy, variants that leave some residual activity may be linked to later or milder disease, while loss-of-function variants can have a stronger effect.
How variants are linked to conditions
Pathogenic variants in the TRIM63 gene are most clearly linked to hypertrophic cardiomyopathy, a condition where the heart muscle becomes abnormally thick. In published studies, TRIM63 gene variants linked to hypertrophic cardiomyopathy are often found in people who inherit a disease causing variant from both parents. Some may also have heart rhythm changes or more scarring seen on heart imaging.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are widely found in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that clearly increase or reduce risk related to the TRIM63 gene. In families with a disease-causing TRIM63 change, risk is mainly shaped by the inherited variant itself, while age, other genes, and general heart health may influence how strongly symptoms show up.
Inheritance of TRIM63 variants
For families learning about TRIM63 gene inheritance, the best established pattern is autosomal recessive. This means a person usually inherits one TRIM63 variant from each parent before developing a TRIM63-related heart condition. Parents who each carry one variant often do not have the condition themselves. With each pregnancy, two carrier parents have a 25% chance of having a child with the condition, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with no inherited variant in the TRIM63 gene.
What does my TRIM63 result mean for my family?
For TRIM63, family implications are usually discussed in a recessive pattern. This often means parents are healthy carriers, brothers and sisters may also have the condition or be carriers, and children of an affected person will usually be carriers unless the other parent also carries a TRIM63 change. Close relatives may want to review the result in the context of the family history.
Genetic information
Genetic testing
How you find out about variants
Testing for variants in the TRIM63 gene usually involves a blood or saliva sample sent for TRIM63 genetic testing, often as part of a cardiomyopathy panel. A lab reads the DNA sequence to look for changes and may also check for missing or extra pieces, then classifies any variant by its known clinical significance.
When should I consider getting a genetic test?
Consider genetic testing for the TRIM63 gene if you or close relatives have unexplained thickening of the heart muscle, especially at a young age or in more than one family member. A TRIM63 change can help explain some inherited heart muscle conditions and may help guide family screening.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it reveals depends on the condition and on the type of variant involved. Over time, many factors influence how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides added context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. A treatment that works well for one person may work less well for another, or may cause more side effects, because the body can absorb, break down, or clear the drug differently. These differences are common and are one reason medication response is not the same for everyone. In some cases, inherited DNA changes can help explain why a person is more sensitive to a medicine or gets less benefit from it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way people respond to medicines. It focuses on the relationship between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medications, genes can influence how strongly a drug works or how the body handles it. This understanding can support more informed and individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the TRIM63 gene
When should I seek medical advice?
There isn't yet a broadly confirmed role for this gene in guiding medication response, so general questions about medicines, side effects, or how well a treatment is working are best discussed with your doctor. Seek medical advice promptly if you develop new chest pain, fainting, shortness of breath, or a racing heartbeat.
History
The TRIM63 gene entered the scientific literature in the early 2000s, when researchers studying muscle wasting identified it as a muscle specific gene that becomes more active during atrophy. It was first widely known by the name MuRF1, short for muscle specific RING finger 1, before being placed within the broader TRIM gene family. From these first observations, research expanded steadily as animal studies showed that blocking this gene could lessen muscle loss in some settings. That work made the TRIM63 gene an important marker in studies of aging, immobilization, heart failure, and other conditions linked to shrinking muscle mass. Over time, scientists’ understanding of the gene’s role has changed as its links to inherited muscle conditions also became clearer.